Aberrant
activation of Bruton’s tyrosine kinase (BTK) plays
an important role in pathogenesis of B-cell lymphomas, suggesting
that inhibition of BTK is useful in the treatment of hematological
malignancies. The discovery of a more selective on-target covalent
BTK inhibitor is of high value. Herein, we disclose the discovery
and preclinical characterization of a potent, selective, and irreversible
BTK inhibitor as our clinical candidate by using in vitro potency,
selectivity, pharmacokinetics (PK), and in vivo pharmacodynamic for
prioritizing compounds. Compound BGB-3111 (31a, Zanubrutinib) demonstrates (i) potent activity against BTK and
excellent selectivity over other TEC, EGFR and Src family kinases,
(ii) desirable ADME, excellent in vivo pharmacodynamic in mice and
efficacy in OCI-LY10 xenograft models.
The lymphocyte-monocyte ratio (LMR) is a systemic inflammatory marker for prediction of disease development, progress, and survival. Recently, a genome-wide association study identified genetic variations in ITGA4 and HLA-DRB1 that affect the LMR levels and were widely believed to be susceptibility genes for autoimmune diseases, including rheumatoid arthritis (RA). However, the role of LMR in RA patients remains unclear. The LMR level and other laboratory data of 66 RA patients, 163 osteoarthritis (OA) patients, and 131 healthy controls (HC) were compared using binary logistic regression. The correlations between LMR and disease activity and other inflammatory markers were measured using the Spearman rank test. ROC curve analyses assessed the diagnostic accuracy of LMR in RA. The LMR and lymphocyte count were significantly lower in RA patients, whereas the monocyte count was significantly higher relative to the HC group/OA patients (p < 0.01). A decreased LMR has been associated with increased disease activity (p = 0.012). In addition, the DAS28 and traditional inflammatory markers, including ESR, CRP, RDW, PLR, and NLR, and immune-related factors, such as C4, IgA, and IgM, were inversely correlated with LMR, while hemoglobin and albumin were positively correlated with LMR. The ROC curve showed that the area under the curve of LMR was 0.705 (95%CI = 0.630-0.781). The corresponding specificity and sensitivity were 82.82 and 45.45%, respectively. The present study shows that the LMR is an important inflammatory marker which could be used to identify disease activity in RA patients and to distinguish RA from OA patients.
The relationship among the gut microbiome, global fecal metabolites and rheumatoid arthritis (RA) has not been systematically evaluated. In this study, we performed 16S rDNA sequencing and liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based nontargeted metabolomic profiling on feces of 26 untreated RA patients and 26 healthy controls. Twenty-six genera and forty-one MS2-identified metabolites were significantly altered in the RA patients. Klebsiella, Escherichia, Eisenbergiella and Flavobacterium were more abundant in the RA patients, while Fusicatenibacter, Megamonas and Enterococcus were more abundant in the healthy controls. Function prediction analysis demonstrated that the biosynthesis pathways of amino acids, such as L-arginine and aromatic amino acids, were depleted in the RA group. In the metabolome results, fecal metabolites including glycerophospholipids (PC(18:3(9Z,12Z,15Z)/16:1(9Z)), lysoPE 19:1, lysoPE 18:0, lysoPC(18:0/0:0)), sphingolipids (Cer(d18:0/16:0), Cer(d18:0/12:0), Cer(d18:0/14:0)), kynurenic acid, xanthurenic acid and 3-hydroxyanthranilic acid were remarkably altered between the RA patients and healthy controls. Dysregulation of pathways, such as tryptophan metabolism, alpha-linolenic acid metabolism and glycerophospholipid metabolism, may contribute to the development of RA. Additionally, we revealed that the gut microbiome and metabolites were interrelated in the RA patients, while Escherichia was the core genus. By depicting the overall landscape of the intestinal microbiome and metabolome in RA patients, our study could provide possible novel research directions regarding RA pathogenesis and targeted therapy.
To date, the fused-ring electron acceptors show the best photovoltaic performances, and the development of simple non-fullerene acceptors via intramolecular noncovalent interactions can reduce synthetic costs. In this work, four simple non-fullerene acceptors with an A-D-A'-D-A configuration (QCIC1, QCIC2, QCIC3, and QCIC4) were synthesized. They contained the same conjugated backbone (A': quinoxaline; D: cyclopentadithiophene; A: dicyano-indanone) but different halogen atoms and alkyl side chains. Due to the chlorination on the end-groups and the most and/or longest branched alkyl side chains on the backbone, the blended film composed of QCIC3 and donor poly{[2,6'-4,8-di(5-ethylhexylthienyl)benzo [1,2-b : 4,5-b']dithiophene]-alt- [5,5-(1',3'-di-2-thienyl-5',7'-bis(2ethylhexyl)benzo [1',2'-c : 4',5'-c']dithiophene-4,8-dione)]} (PBDB-T) exhibited the strongest π-π stacking and the most suitable phase-separation domains among the four blended films. Therefore, the QCIC3-based organic solar cells yielded the highest power conversion efficiency of 10.55 %. This work provides a pathway to optimize the molecular arrangements and enhance the photovoltaic property of simple electron acceptors through subtle chemical modifications.
Overgrinding of Portland cement brings excessive shrinkage and poor self-healing ability to concrete. In this paper, through the ultrasonic test and optical micrograph observation, the self-healing properties of concrete prepared by cement with different particle size distributions were studied. Besides, the effect of carbonation and continued hydration on self-healing of concrete was analyzed. Results show that, for the Portland cement containing more particles with the size 30~60 μm, the concrete could achieve a better self-healing ability of concrete at 28 days. For the two methods to characterize the self-healing properties of concrete, the ultrasonic test is more accurate in characterizing the self-healing of internal crack than optical micrograph observation. The autogenous self-healing of concrete is jointly affected by the continued hydration and carbonation. At 7 days and 30 days, the autogenous self-healing of concrete is mainly controlled by the continued hydration and carbonation, respectively. The cement particle size could affect the continued hydration by affecting un-hydrated cement content and the carbonation by affecting the Ca(OH)2 content. Therefore, a proper distribution of cement particle size, which brings a suitable amount of Ca(OH)2 and un-hydrated cement, could improve the self-healing ability of concrete.
This paper describes the reversible phase transition behavior of a thermoresponsive poly(N-isopropylacrylamide) (PNIPAM) shell at the surface of a hydrophilic core. Reversible addition-fragmentation transfer (RAFT) polymerization of N-isopropylacrylamide was conducted using a hydrophilic hyperbranched poly(glycidol) (HPG)-based macroRAFT agent. At lower temperatures (o30 1C), the resultant multiarm star block copolymer (HPG-PNIPAM) exists as unimolecular micelles, with hydrophilic HPG as the core and a densely grafted PNIPAM brush as the shell. In laser light scattering (LLS) studies, the concentration used for HPG-PNIPAM is 5Â10 À6 g ml À1 , to avoid any possible aggregation between dendritic unimolecular micelles above the lower critical solution temperature (B32 1C) of PNIPAM. What we observe for the phase transition of HPG-PNIPAM involves only unimolecular process. A combination of dynamic and static LLS studies of HPG-PNIPAM in aqueous solution reveals a reversible phase transition on heating and cooling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.